Where does United Therapeutics Corporation rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), United Therapeutics Corporation ranks #4,174 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does United Therapeutics Corporation hold?

United Therapeutics Corporation holds 86 US utility patents granted between 2015 and 2025, spanning 29 technology areas.

What is United Therapeutics Corporation's Innovation Score?

United Therapeutics Corporation has an Innovation Score of 52.9 out of 100 (top 9% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does United Therapeutics Corporation focus on?

United Therapeutics Corporation's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 62 patents, ranking #273 of 6,058 assignees active in that subclass. Grants appear in 29 CPC subclasses total.

Is United Therapeutics Corporation's patent grant rate increasing or decreasing?

United Therapeutics Corporation's recent grant velocity is -2% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for United Therapeutics Corporation's patents?

United Therapeutics Corporation's patents average 15.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the United Therapeutics Corporation patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

United Therapeutics Corporation

USPTO PatentsView assignee record - 86 granted patents across 29 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, United ranks #4,174 of 49,997 tracked US assignees by granted-patent volume, with 86 patents across 29 technology areas.

#4,174
of 49,997 US assignees by volume: Top 9%
by Innovation Score (52.9/100): 15.8
avg claims per patent: -2%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4174 · US Corporation #4,174 · 86 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 86 grants
TOP-DECILE #4,174/49,997
PHOTO-FINISH Radian Memory…
CPC-FOCUS A61P · 29 areas
INNOV-PAR 52.9/100
CLAIMS-RICH 15.8 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT -2% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Radian Memory Systems, Illc (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How United’s 52.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 15.4 pts (29%) Velocity 9.0 pts (17%) Breadth 19.0 pts (36%) Claim depth 9.5 pts (18%)

Qualcomm Incorporated · highest

85
Mbda France · near

53
Nippon Steel… · near

53
Rochester Institute… · near

53
Toshiba Digital… · near

53
United Therapeutics · this assignee

53
3D Lighting… · lowest

7

What this shows United's Innovation Score is 52.9/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for United?

Each dot is one of United’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). United’s own 15.8 claims/patent is ABOVE the 12.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

United vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where United's grants concentrate

United Therapeutics Corporation is a focused PatentsView assignee: 29 CPC subclasses with 72.1% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2023 (15 grants) versus a trough of 5 in 2021. By volume, United sits between Radian Memory Systems, Illc and Archer Aviation Inc..

United's three-year grant acceleration

From 2019–2021 to 2022–2024, United Therapeutics Corporation moved from 20 to 27 grants (1.35x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Radian Memory Sys…

86
Sata & KG

86
Syncmold Enterpri…

86
Telia AB

86
Wavefront Research

86
United Therapeuti… ◀

86
Accton Technology

85
Alfred Kärcher &…

85
Archer Aviation

85

What this shows United holds 86 patents at rank #4,174, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near United

By rank, the assignees closest to #4,174 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in United's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for United, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), United ranks #273 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (53 here).

Rochester Institute of Technology 53 Toshiba Digital Solutions Corporation 53 Mbda France 53 Nippon Steel Chemical & Material Co., Ltd. 53

Similar claim depth

Nearest assignees by average claims per patent (15.8 here).

Bestway Inflatables & Material Corp. 15.8 avg Dow Corning Corporation 15.8 avg Sunpower Corporation 15.8 avg Essilor International 15.8 avg

United's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

53 Top 9% higher than 91% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

United Therapeutics Corporation patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	9	10.5%
2016	6	7.0%
2017	10	11.6%
2018	9	10.5%
2019	7	8.1%
2020	8	9.3%
2021	5	5.8%
2022	5	5.8%
2023	15	17.4%
2024	7	8.1%
2025partial year	5	5.8%

Which technologies does United Therapeutics Corporation patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 62

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 56

C07C - Acyclic OR Carbocyclic Compounds 35

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 13

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 12

C07D - Heterocyclic Compounds 9

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 9

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 7

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 5

C07K - Peptides 4

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 4

B01D - Separation 3

Y02A - Technologies FOR Adaptation TO Climate Change 3

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 2

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 2

Top 15 of 29 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

United Therapeutics Corporation's patent record in context - here's where to go next.

United Therapeutics Corporation's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 72.1% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #4,174 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare United Therapeutics Corporation against Radian Memory Systems, Illc, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 52.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.